Publication | Open Access
Lack of Clinical Benefit of Improved Angiographic Results With Sirolimus-Eluting Stents Compared With Paclitaxel and Zotarolimus-Eluting Stents in Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention
10
Citations
21
References
2009
Year
The angiographic benefit of SES did not translate into a clinical benefit for up to 1 year in AMI patients.
| Year | Citations | |
|---|---|---|
Page 1
Page 1